Associated Papers
Favourable Prognostic Significance of HER2 Mutations in Canine Pulmonary Adenocarcinoma Following Surgical Resection.
Ichimata M et al.
Veterinary and Comparative Oncology, 2025
Trastuzumab deruxtecan for the treatment of metastatic non-small cell lung cancer harboring HER2 non-exon 19/20 mutations: four case reports.
Meng Y et al.
Frontiers in Immunology, 2025
Protein Expression, Amplification, and Mutation of HER2 Gene in Canine Primary Pulmonary Adenocarcinomas: Preliminary Results.
Brunetti B et al.
Animals : an Open Access Journal From Mdpi, 2024
Next-Generation Sequencing in Lung Cancers-A Single-Center Experience in Taiwan.
Lai WA et al.
Medicina (kaunas, Lithuania), 2024
38399524 (PubMed )
Supplement: medicina-60-00236-s001.zip › Supplementary_figures.pdf
Next generation sequencing and genomic mapping: towards precision molecular diagnosis of lung cancer in Morocco.
Morjani O et al.
The Pan African Medical Journal, 2024
BRCA1 and NORE1A Form a Her2/Ras Regulated Tumor Suppressor Complex Modulating Senescence.
Nelson N et al.
Cancers, 2023
Identification of Activating Mutations in the Transmembrane and Extracellular Domains of EGFR.
Wagner A et al.
Biochemistry, 2022
Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.
Hu C et al.
Journal for Immunotherapy of Cancer, 2021
Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.
Mack PC et al.
Cancer, 2020
Molecular features of lung adenocarcinoma in young patients.
Chen Z et al.
Bmc Cancer, 2019
Insight into the recognition patterns of the ErbB receptor family transmembrane domains: heterodimerization models through molecular dynamics search.
Samna Soumana O et al.
European Biophysics Journal : Ebj, 2008
ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner.
Ren Z et al.
The Journal of Biological Chemistry, 2002
Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent association.
Penuel E et al.
The Journal of Biological Chemistry, 2002
Molecular modeling of c-erbB2 receptor dimerization: coiled-coil structure of wild and oncogenic transmembrane domains--stabilization by interhelical hydrogen bonds in the oncogenic form.
Garnier N et al.
Biopolymers, 1997
Detailed description of an alpha helix-->pi bulge transition detected by molecular dynamics simulations of the p185c-erbB2 V659G transmembrane domain.
Duneau JP et al.
Journal of Biomolecular Structure & Dynamics, 1996
Select a paper to view details